Cargando…
Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy
Cancer is a worldwide health problem. Personalized treatment represents a future advancement for cancer treatment, in part due to the development of targeted therapeutic drugs. These molecules are expected to be more effective than current treatments and less harmful to normal cells. The discovery a...
Autores principales: | Wu, Zherui, Martinez-Fong, Daniel, Trédaniel, Jean, Forgez, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547287/ https://www.ncbi.nlm.nih.gov/pubmed/23335914 http://dx.doi.org/10.3389/fendo.2012.00184 |
Ejemplares similares
-
Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib
por: Younes, Mohamad, et al.
Publicado: (2014) -
Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced Obesity
por: Wu, Zherui, et al.
Publicado: (2021) -
Neurotensin and its receptors in the control of glucose homeostasis
por: Mazella, Jean, et al.
Publicado: (2012) -
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice
por: Dupouy, Sandra, et al.
Publicado: (2014) -
The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression
por: Dupouy, Sandra, et al.
Publicado: (2009)